merozan 1000mg/vial powder for solution for injection
demo s.a. (0000003568) 21st km national road athens-lamia, krioneri, attiki, 14568 - meropenem trihydrate - powder for solution for injection - 1000mg/vial - meropenem trihydrate (8000001535) 1140mg
pamidronate disodium
pharmaceutical trading co ltd - ΤΟ pamidronate disodium - solution for infusion, concentrate for - 90mg/10ml - 8000001289 - disodium pamidronate - 9 mg base - pamidronic acid
warimazol 1% vaginal cream
costakis tsisios & co. ltd (0000011631) 22 filopoimenos str., mesa geitonia, limassol, 4002 - clotrimazole - vaginal cream - 1% - clotrimazole (0023593751) 1g - clotrimazole
selevit, solution for injection for calves, lambs, swine, horses
qa11aa03 - granted - fatro spa italy - n. a. chance trading co
dalmazin, 75 micrograms/ml, solution for injection for cows and sows
qg02ad90 - granted - fatro spa italy - 0.075 mg/ml - d-cloprostenol (8900000219) 0.075mg - cloprostenol - n. a. chance trading co
ambisome 50mg/vial powder for concentr.for liposomal dispers.for inf.
gilead sciences ireland uc (0000009744) ida business & technology park, county cork, carrigtohill, t45 dp77 - amphotericin b - powder for concentr.for liposomal dispers.for inf. - 50mg/vial - amphotericin b (0001397893) 50mg - amphotericin
montelukast pharmassist 4mg/tab μασωμενο δισκιο
ΦΑΡΜΑΣΙΣΤ Μ.Ε.Π.Ε. - Μοντελουκάστη νατρίου - ΜΑΣΩΜΕΝΟ ΔΙΣΚΙΟ - 4mg/tab - ineof01106 - montelukast sodium - 4.160000 mg - montelukast
montelukast pharmassist 5mg/tab μασωμενο δισκιο
ΦΑΡΜΑΣΙΣΤ Μ.Ε.Π.Ε. - Μοντελουκάστη νατρίου - ΜΑΣΩΜΕΝΟ ΔΙΣΚΙΟ - 5mg/tab - ineof01106 - montelukast sodium - 5.200000 mg - montelukast
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - Η Σκλήρυνση Κατά Πλάκας, Υποτροπιάζουσα-Διαλείπουσα - Ανοσοκατασταλτικά - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
influvac sub-unit(αντιγριπικο) (15+15+15)mcg/0,5ml pf.syr (1δόση) ενεσιμο εναιωρημα σε προγεμισμενη συριγγα
bgp ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. bgp ΠΡΟΪΟΝΤΑ Μ.Ε.Π.Ε. (0000011228) Αγ. Δημητρίου 63, Α - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224); b/washington/02/2019 - like strain (b/washington/02/2019, wild type) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15)mcg/0,5ml pf.syr (1δόση) - ineof03055 a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15.000000 mcg; ineof03056 a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224) 15.000000 mcg; ineof03029 b/washington/02/2019 - like strain (b/washington/02/2019, wild type) 15.000000 mcg - influenza, purified antigen